Amy Sung

1.2k total citations
14 papers, 898 citations indexed

About

Amy Sung is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Amy Sung has authored 14 papers receiving a total of 898 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Amy Sung's work include Peptidase Inhibition and Analysis (5 papers), Protease and Inhibitor Mechanisms (5 papers) and Blood Coagulation and Thrombosis Mechanisms (3 papers). Amy Sung is often cited by papers focused on Peptidase Inhibition and Analysis (5 papers), Protease and Inhibitor Mechanisms (5 papers) and Blood Coagulation and Thrombosis Mechanisms (3 papers). Amy Sung collaborates with scholars based in United States, Canada and United Kingdom. Amy Sung's co-authors include Mark L. Day, Robert L. Arias, Rachel L. Navarra, Barry M. Weichman, Keith B. Glaser, Karen L. Marquis, Jean Bauer, Feng Liu, Nicholas J. Brandon and Ronald F. Mervis and has published in prestigious journals such as Nature Neuroscience, Brain Research and Journal of Medicinal Chemistry.

In The Last Decade

Amy Sung

14 papers receiving 878 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amy Sung United States 13 309 285 198 178 154 14 898
Kathleen M. Ogilvie United States 19 717 2.3× 201 0.7× 189 1.0× 191 1.1× 314 2.0× 35 1.5k
Yves Mérand Canada 24 545 1.8× 816 2.9× 396 2.0× 308 1.7× 97 0.6× 49 1.6k
Andrew Midzak Canada 16 577 1.9× 165 0.6× 278 1.4× 165 0.9× 85 0.6× 19 1.2k
N. Boujrad United States 14 622 2.0× 150 0.5× 161 0.8× 425 2.4× 68 0.4× 19 1.1k
Françoise Cadepond France 13 452 1.5× 268 0.9× 186 0.9× 150 0.8× 77 0.5× 25 821
Virginia Pulito United States 14 557 1.8× 295 1.0× 268 1.4× 278 1.6× 136 0.9× 24 1.3k
K.M. Rajkowski France 17 403 1.3× 181 0.6× 193 1.0× 144 0.8× 109 0.7× 36 842
Caterina Cascio Italy 20 550 1.8× 162 0.6× 197 1.0× 379 2.1× 181 1.2× 29 1.2k
Magdalena Schräder Switzerland 14 764 2.5× 585 2.1× 149 0.8× 171 1.0× 43 0.3× 16 1.3k
Martin Missbach Switzerland 19 765 2.5× 133 0.5× 59 0.3× 190 1.1× 43 0.3× 25 1.6k

Countries citing papers authored by Amy Sung

Since Specialization
Citations

This map shows the geographic impact of Amy Sung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Sung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Sung more than expected).

Fields of papers citing papers by Amy Sung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Sung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Sung. The network helps show where Amy Sung may publish in the future.

Co-authorship network of co-authors of Amy Sung

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Sung. A scholar is included among the top collaborators of Amy Sung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Sung. Amy Sung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Grauer, Steven M., Radka Graf, Rachel L. Navarra, et al.. (2008). WAY-163909, a 5-HT2C agonist, enhances the preclinical potency of current antipsychotics. Psychopharmacology. 204(1). 37–48. 18 indexed citations
2.
Liu, Feng, Mark L. Day, Daniel Bitran, et al.. (2008). Activation of estrogen receptor-β regulates hippocampal synaptic plasticity and improves memory. Nature Neuroscience. 11(3). 334–343. 410 indexed citations
3.
Fleming, Ian, et al.. (2005). A synthesis of (±)-sparteine. Organic & Biomolecular Chemistry. 3(8). 1557–1567. 12 indexed citations
4.
Day, Mark L., Amy Sung, Sheree F. Logue, Mark R. Bowlby, & Robert L. Arias. (2005). Beta estrogen receptor knockout (BERKO) mice present attenuated hippocampal CA1 long-term potentiation and related memory deficits in contextual fear conditioning. Behavioural Brain Research. 164(1). 128–131. 58 indexed citations
5.
Beyer, Chad E., Afshin Ghavami, Qian Lin, et al.. (2004). Regulators of G-protein signaling 4: modulation of 5-HT1A-mediated neurotransmitter release in vivo. Brain Research. 1022(1-2). 214–220. 27 indexed citations
6.
7.
Grosu, G, Baihua Hu, John W. Ellingboe, et al.. (2003). Synthesis and Structure−Activity Relationship of α-Sulfonylhydroxamic Acids as Novel, Orally Active Matrix Metalloproteinase Inhibitors for the Treatment of Osteoarthritis. Journal of Medicinal Chemistry. 46(12). 2361–2375. 47 indexed citations
8.
Chen, James, Guixian Jin, Amy Sung, & Jeremy I. Levin. (2002). Anthranilate sulfonamide hydroxamate TACE inhibitors. Part 1: Structure-based design of novel acetylenic P1′ groups. Bioorganic & Medicinal Chemistry Letters. 12(8). 1195–1198. 38 indexed citations
9.
Nelson, Frances C., Efren Delos Santos, Jeremy I. Levin, et al.. (2002). Benzodiazepine inhibitors of the MMPs and TACE. Bioorganic & Medicinal Chemistry Letters. 12(20). 2867–2870. 22 indexed citations
10.
Levin, Jeremy I., Yansong Gu, Frances C. Nelson, et al.. (2001). Heteroaryl and cycloalkyl sulfonamide hydroxamic acid inhibitors of matrix metalloproteinases. Bioorganic & Medicinal Chemistry Letters. 11(2). 239–242. 16 indexed citations
11.
Levin, Jeremy I., John F. DiJoseph, Loran M. Killar, et al.. (2001). The discovery of anthranilic acid-based MMP inhibitors. Part 1: SAR of the 3-position. Bioorganic & Medicinal Chemistry Letters. 11(2). 235–238. 36 indexed citations
12.
Levin, Jeremy I., John F. DiJoseph, Loran M. Killar, et al.. (1998). The synthesis and biological activity of a novel series of diazepine MMP inhibitors. Bioorganic & Medicinal Chemistry Letters. 8(19). 2657–2662. 27 indexed citations
13.
Glaser, Keith B., Amy Sung, Jean Bauer, & Barry M. Weichman. (1993). Regulation of eicosanoid biosynthesis in the macrophage. Biochemical Pharmacology. 45(3). 711–721. 90 indexed citations
14.
Jacobson, Peer B., Lisa A. Marshall, Amy Sung, & Robert S. Jacobs. (1990). Inactivation of human synovial fluid phospholipase a2 by the marine natural product, manoalide. Biochemical Pharmacology. 39(10). 1557–1564. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kathleen M. Ogilvie Breakdown of academic impact, for papers by Yves Mérand Breakdown of academic impact, for papers by Andrew Midzak Breakdown of academic impact, for papers by N. Boujrad Breakdown of academic impact, for papers by Françoise Cadepond Breakdown of academic impact, for papers by Virginia Pulito Breakdown of academic impact, for papers by K.M. Rajkowski Breakdown of academic impact, for papers by Caterina Cascio Breakdown of academic impact, for papers by Magdalena Schräder Breakdown of academic impact, for papers by Martin Missbach
Rankless by CCL
2026